Haemostatic factors in women with history of Preeclampsia

被引:13
|
作者
Portelinha, Ana [1 ]
Cerdeira, Ana Sofia [2 ]
Belo, Luis [3 ]
Braga, Jorge [2 ]
Tejera, Eduardo [3 ]
Pinto, Ana [4 ]
Pinto, Fatima [4 ]
Areias, Maria Jose [4 ]
Patricio, Belmiro [5 ]
Rebelo, Irene [3 ]
机构
[1] Univ Porto, Serv Bioquim, Fac Farm, Inst Mol & Cell Biol, P-4050047 Oporto, Portugal
[2] Hosp Geral Sto Antonio, Dept Gynecol & Obstet, Oporto, Portugal
[3] Univ Porto, Fac Pharm, Dept Biochem, Oporto, Portugal
[4] Maternidade Julio Dinis, Dept Obstet, Oporto, Portugal
[5] Univ Porto, Hosp Sao Joao, Dept Gynecol & Obstet, P-4050047 Oporto, Portugal
关键词
Cardiovascular disease; D-dimer; PAI-1; Preeclampsia; t-PA; fibrinogen; haemostatic factors; FIBRIN D-DIMER; ISCHEMIC-HEART-DISEASE; TISSUE-PLASMINOGEN ACTIVATOR; FETAL-GROWTH-RETARDATION; PREGNANCY COMPLICATIONS; CARDIOVASCULAR-DISEASE; ENDOTHELIAL DYSFUNCTION; MYOCARDIAL-INFARCTION; RISK; PLASMA;
D O I
10.1016/j.thromres.2008.10.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Evaluation of haemostatic parameters - Plasma tissue plasminogen activator (t-PA), plasminogen activator inhibitor type I (PAI-1) and fibrin fragment D-dimer several years after the end of pregnancy to investigate if they are modified in women with history of preeclampsia (PE). Study design: 65 healthy women with history of PE and 54 control women with previous normal pregnancy were enrolled in this study. Groups were matched for age, time period since delivery, smoking status and alcohol consumption. t-PA, PAI-1 and fibrin fragment D-dimer antigen levels were quantified using standards commercial ELISA methods. Plasma fibrinogen was measured using automated capillary zone electrophoresis. Results: Systolic and diastolic blood pressures were higher in women with history of PE. Levels of t-PA, PAI-1 and fibrinogen were similar between groups as well as the t-PA/PAI-1 ratio. A significant increase in D-dimer levels was observed in women with history of PE. Conclusion: The increase in D-dimer level suggests an abnormal haemostatic potential namely increased intravascular coagulation. This, together with the increased blood pressure, can reflect a tendency for an increased risk of cardiovascular/thrombotic events later in life. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:52 / 56
页数:5
相关论文
共 50 条
  • [41] Risk Factors Of Preeclampsia Among Pregnant Women In Indonesia
    Fitriani, Hemi
    Setya, Achmad R.
    Keni, Marcelina
    4TH INTERNATIONAL VIRTUAL CONFERENCE ON NURSING, 2021, : 836 - 841
  • [42] Excretion of angiogenic factors in women with severe preeclampsia (PE)
    Buhimschi, CS
    Magliore, L
    Funai, E
    Norwitz, ER
    Kuczynski, E
    Martin, R
    Richman, S
    Guller, S
    Lockwood, CL
    Buhimschi, IA
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (06) : S70 - S70
  • [43] Preeclampsia; prevalence and risk factors in women with diabetes mellitus
    El Rahman, A. Abd
    Mc Carthy, A.
    Firth, R. G.
    Daly, S.
    Kinsley, B.
    DIABETOLOGIA, 2009, 52 : S461 - S462
  • [44] Fractional excretion of angiogenic factors in women with severe preeclampsia
    Buhimschi, Catalin S.
    Magloire, Lissa
    Funai, Edmund
    Norwitz, Errol R.
    Kuczynski, Edward
    Martin, Ryan
    Richman, Susan
    Guller, Seth
    Lockwood, Charles J.
    Buhimschi, Irina A.
    OBSTETRICS AND GYNECOLOGY, 2006, 107 (05): : 1103 - 1113
  • [45] Serum AMH levels in women with a history of early onset preeclampsia indicate a role for vascular factors in ovarian ageing
    Yarde, F.
    Maas, A. H. E. M.
    Franx, A.
    Eijkemans, M. J. C.
    Drost, J. T.
    van Rijn, B. B.
    van Eyck, J.
    van der Schouw, Y. T.
    Broekmans, F. J. M.
    HUMAN REPRODUCTION, 2013, 28 : 317 - 318
  • [46] The effect of parity, history of preeclampsia, and pregnancy care on the incidence of subsequent preeclampsia in multiparous women with SLE
    Maeda, Yuto
    Kaneko, Kayoko
    Ogawa, Kohei
    Sago, Haruhiko
    Murashima, Atsuko
    MODERN RHEUMATOLOGY, 2021, 31 (04) : 843 - 848
  • [47] Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy
    Norris, LA
    Joyce, M
    O'Keeffe, N
    Sheppard, BL
    Bonnar, J
    MATURITAS, 2002, 43 (02) : 125 - 133
  • [48] How to calculate the risk of preeclampsia in women with a history of positive screening
    Guerby, Paul
    Bujold, Emmanuel
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 223 (02) : 299 - 300
  • [49] Antiphospholipid antibodies and hematological defects in women with a history of preeclampsia or HELLP
    Schneider, DM
    Heilmann, L
    von Tempelhoff, GF
    Kuse, S
    Knirsch, K
    THROMBOSIS AND HAEMOSTASIS, 1999, : 383 - 384
  • [50] Physical well-being in women with a history of severe preeclampsia
    Roes, EM
    Raijmakers, MTM
    Schoonenberg, M
    Wanner, N
    Peters, WHM
    Steegers, EAP
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2005, 18 (01): : 39 - 45